Last reviewed · How we verify
2011-2012 FluMist®
FluMist®, developed by Stanford University, is a marketed influenza vaccine with a key composition patent expiring in 2028. The primary strength of FluMist® lies in its unique mechanism of delivery, offering a needle-free alternative to traditional flu vaccines. The primary risk is the competitive landscape, with multiple established flu vaccines in the market.
At a glance
| Generic name | 2011-2012 FluMist® |
|---|---|
| Also known as | Live, attenuated influenza vaccine (LAIV), FDA-licensed seasonal influenza vaccine |
| Sponsor | Stanford University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe (PHASE4)
- Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) (PHASE4)
- Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS) (PHASE4)
- Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot (EARLY_PHASE1)
- Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide (PHASE2)
- Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women (PHASE2)
- TIV and High Dose TIV in Subjects With Rheumatoid Arthritis (PHASE2)
- Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 2011-2012 FluMist® CI brief — competitive landscape report
- 2011-2012 FluMist® updates RSS · CI watch RSS
- Stanford University portfolio CI